Vicapsys Life Sciences, Inc. (VICP)
OTCMKTS
· Delayed Price · Currency is USD
1.500
0.00 (0.00%)
At close: Dec 3, 2025
Vicapsys Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 0.09 | 0.01 | 0.01 | 0.22 | 0 | 0.26 | Upgrade
|
| Cash & Short-Term Investments | 0.09 | 0.01 | 0.01 | 0.22 | 0 | 0.26 | Upgrade
|
| Cash Growth | 67.32% | -33.16% | -93.51% | 17023.33% | -99.52% | 206.00% | Upgrade
|
| Prepaid Expenses | - | 0.03 | 0.01 | 0.01 | - | - | Upgrade
|
| Other Current Assets | - | - | 0.05 | - | - | - | Upgrade
|
| Total Current Assets | 0.09 | 0.04 | 0.07 | 0.22 | 0 | 0.26 | Upgrade
|
| Other Intangible Assets | - | - | - | 0.37 | 0.4 | 0.43 | Upgrade
|
| Total Assets | 0.09 | 0.04 | 0.07 | 0.59 | 0.4 | 0.7 | Upgrade
|
| Accounts Payable | 1.24 | 0.97 | 0.64 | 0.49 | 0.51 | 0.4 | Upgrade
|
| Accrued Expenses | 0.92 | 0.64 | 0.39 | 0.23 | 0.35 | - | Upgrade
|
| Short-Term Debt | 0.58 | 0.35 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 2.74 | 1.97 | 1.02 | 0.72 | 0.85 | 0.4 | Upgrade
|
| Total Liabilities | 2.74 | 1.97 | 1.02 | 0.72 | 0.85 | 0.4 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 14.37 | 14.34 | 14.14 | 13.98 | 13.42 | 13.4 | Upgrade
|
| Retained Earnings | -17.05 | -16.3 | -15.12 | -14.13 | -13.89 | -13.13 | Upgrade
|
| Comprehensive Income & Other | - | - | 0 | 0.01 | 0 | 0 | Upgrade
|
| Total Common Equity | -2.65 | -1.93 | -0.95 | -0.12 | -0.46 | 0.29 | Upgrade
|
| Shareholders' Equity | -2.65 | -1.93 | -0.95 | -0.12 | -0.45 | 0.3 | Upgrade
|
| Total Liabilities & Equity | 0.09 | 0.04 | 0.07 | 0.59 | 0.4 | 0.7 | Upgrade
|
| Total Debt | 0.58 | 0.35 | - | - | - | - | Upgrade
|
| Net Cash (Debt) | -0.49 | -0.34 | 0.01 | 0.22 | 0 | 0.26 | Upgrade
|
| Net Cash Growth | - | - | -93.51% | 17023.33% | -99.52% | 206.00% | Upgrade
|
| Net Cash Per Share | -0.01 | -0.01 | 0.00 | 0.01 | 0.00 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 32.37 | 32.07 | 31.19 | 30.16 | 30.11 | 17.48 | Upgrade
|
| Total Common Shares Outstanding | 32.37 | 32.07 | 31.19 | 19.75 | 17.48 | 17.48 | Upgrade
|
| Working Capital | -2.65 | -1.93 | -0.95 | -0.49 | -0.85 | -0.13 | Upgrade
|
| Book Value Per Share | -0.08 | -0.06 | -0.03 | -0.01 | -0.03 | 0.02 | Upgrade
|
| Tangible Book Value | -2.65 | -1.93 | -0.95 | -0.49 | -0.86 | -0.14 | Upgrade
|
| Tangible Book Value Per Share | -0.08 | -0.06 | -0.03 | -0.02 | -0.05 | -0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.